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EXECUTIVE SUMMARY 
 
This report was developed in preparation for the international meeting “Ensuring universal 
access: user fee and free care policies in the context of HIV treatment”, sponsored by UNAIDS 
Secretariat, World Health Organization and the World Bank on 21-23 March 2005 in Geneva. 
 
The report considers aspects of gender dimension in access to treatment and the extent to 
which free care or co-payment at the point of service delivery intersect with gender equity in 
access to treatment within the context of scaling up. It provides a strategic analysis to enable 
the development of guidance for policy options. 
 
Method  
The report presents a review of published literature relating to equity of access to prevention 
and treatment services for HIV/AIDS and draws on existing evidence from gender equity 
analyses of access to services for other diseases such as tuberculosis. It also utilises evidence 
from a case study and key informant interviews. 
 
An Internet literature search was conducted using Pub Med, additional grey literature and 
published literature was sourced from individuals in the Gender and Health group. 
 
Four countries (Uganda, Kenya, Malawi, India) were selected for researching case studies and 
conducting key informant interviews. Selection was on the basis of: 
• Experience of provision of free antiretroviral drugs through public, private or NGO services 
• Representation of various stages in progression of the epidemic  
• Existing personal contacts through the Gender and Health Group and the International 
Community of Women Living with HIV 
 
A case study of free antiretroviral provision in Malawi was conducted by Research for Equity 
and Community Health Trust (REACH) using secondary health utilisation data from a service 
provision NGO and an existing qualitative study of the factors influencing access to these 
services.  
 
Key informant interviews were conducted with women living with HIV/AIDS, representatives of 
NGOs, representatives of public health services including programmers and policy makers. 
Most interviews were conducted either face to face or by telephone, but some informants 
preferred to answer questions through written correspondence.  This is not a representative 
sample of key informants, but was purposively selected to indicate a range of experiences and 
perspectives from these groups. Analysis of these interviews was carried out using a framework 
approach. 
 
1.  Why is gender important in antiretroviral therapy (ART) provision? 
 
Globally, young women are 1.6 times more likely to be living with HIV/AIDS than young men, a 
figure that rises to three times more likely in sub Saharan Africa. In 2003, 13 million adult (15-
49) women in sub Saharan Africa were living with the virus compared to just under 10 million 
adult men.  
 
Rates of ART usage are extremely low in resource poor settings. Only 2% of the total number of 
people receiving treatment live in Africa and less than 8% of people in the South who need ART 
are receiving drug treatment. Many international donors have focused efforts on scaling up 
ART. “3 by 5” is the global target of the World Health Organisation (WHO) and UNAIDS to get 
three million people living with HIV/AIDS in the South on ART by the end of 2005. 
  
There is little published information disaggregated by gender, age or socio-economic status to 
indicate who is accessing ART in resource poor contexts. However, where data is available, it 
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suggests that access to ART is often most common amongst educated men living in urban 
areas. Evidence suggests that poor women appear to be at particular disadvantage in 
accessing HIV treatment. Furthermore there are some groups of women who appear excluded 
from mainstream HIV services, such as commercial sex workers, intravenous drug abusers, HIV 
positive women who are pregnant or have children. These inequities in access are likely to 
continue or worsen when ART is made more widely available unless specific measures are 
taken to address this in scale-up.  
 
2.  Why is there gender inequity in access to ART? 
 
There are many factors that shape the inequitable access to services by women and men: 
 
Where there are direct costs for ART, both poor women and men have limited ability to access 
ART. However, women often do not have equal access to those resources available within 
households, where a male head will often decide how financial resources are allocated. Where 
a household has only sufficient resources for one member to receive ART when more are in 
need, it will usually be the male head who takes priority. Where women have some independent 
access to financial resources, they may forgo food or other essentials to pay for health care, or 
alternatively not seek health care. Where women care for children, they will often put providing 
for the child before their own health care needs. 
 
Even if treatment is free, other indirect costs that are incurred can prevent women’s access to 
treatment. Frequent journeys to and from health facilities for drugs and monitoring can be both 
expensive and difficult to access. Many poor women are unable to access services due to the 
need to earn, or produce food for their families. Even without these financial constraints, 
women’s domestic responsibilities mean they find it difficult to leave their families to travel to a 
clinic. Many types of ART require certain amounts and types of food. In situations where poverty 
limits the amount of food available and where women are the last to eat, it can be almost 
impossible for them to take ART effectively without additional support. 
 
The stigma of living with HIV/AIDS, although affecting both sexes, is often more extensively 
directed against women than against men. Social stigma often perpetuates the belief that HIV 
infection is a result of promiscuity or prostitution, labels which may lead to blame or violence for 
women, preventing them from accessing treatment. Many women fear being abandoned by 
their partners or families, on whom they are often dependent, which discourages them from 
discovering or admitting their HIV status. 
 
The poor quality of healthcare services can act as a barrier to access and utilisation. 
Attitudes of health care staff can prevent poor and vulnerable women from using health 
services. Lack of privacy and confidentiality in services can mean that fear of stigma, 
discrimination and violence due to their HIV status prevents women from accessing care. 
Where corruption within the health system can result in exemption from user fees being 
overlooked or misinterpreted women find it difficult to negotiate their treatment. Gendered 
norms and stereotypes within the health system can affect what treatment women and men 
receive and how quickly.  
 
The shortage in human resources, lack of training in providing ART, and poor distribution 
logistics mean that even if women try to access treatment, the clinical quality of services is 
poor. 
 
Women frequently do not have sufficient information with which to make effective decisions 
about healthcare, such as information regarding where to find and how to access appropriate 
services. They do not have sufficient knowledge about how to treat symptoms and may be 
misinformed about the risks of ART.  
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Women may also have limited control over their mobility and time. A woman may not be 
able to access health services because society restricts her movements or a woman’s husband 
may prevent her from obtaining treatment. 
 
Women’s status in the household and in society often means that they are not used to 
expressing their own needs. They may find it particularly difficult to discuss sexual health 
problems. Some women do not want to worry their families or be a financial burden.  
 
3.   Will free provision improve gender equity? 
 
As indicated in the previous section, cost is a critical issue in women’s access to ART. There is 
evidence that even when costs of ART are drastically reduced, it still remains out of reach for 
many poor women. There is very little published analysis on the impact of free ART on gender 
equity. However, key informant interviews and a case study reveal that free provision of ART 
can improve access to services by women. Free access should improve access for women in 
the following ways:  
• Women are not dependent on their husbands or partners for purchasing treatment  
• Stigma will be reduced as more people access ART and thus look healthy and are able to 
work  
• Poor women who are divorced, separated, widowed or unmarried will particularly benefit as 
their income is unlikely to be sufficient to purchase ART and because they may not have 
anyone to support them if they lose their source of income once they become ill 
 
4.  How can we ensure free ART delivers gender equity in access to ART? 
 
As there are many factors, including cost, that influence women’s access to ART, it is necessary 
to devise a package of free access that would help ensure gender equity in access to the 
services. An examination of WHO’s minimum set of requirements for making ART available 
through a gendered lens provides an entry point into developing this package.  Additional 
recommendations will further improve gender equity. 
 
Engendering the WHO minimum requirements for ART provision 
• Reducing or eliminating costs of HIV tests, other laboratory tests and consultations in order 
that women can gain access to them 
• VCT services should develop and follow a set of best practice guidelines, which take into 
account the specific needs and priorities of different groups of women 
• Taking measures to reduce stigma in the provision of all services 
• Training for staff to raise awareness of gender issues and the effects of discriminatory and 
unethical practices, and disciplinary measures to prevent these practices 
• Training for staff to improve the quality of information given to clients, including messages to 
dispel common myths discouraging women from accessing treatment 
• Training for staff in clinical issues relating to women with HIV 
• Initiating or working with formal and informal support and advocacy networks of women 
living with HIV/AIDS at local, regional, national and international levels 
• Developing a formal network of HIV service providers, both clinical and non-clinical, to 
improve linkages between public, private and NGO providers, building on their strengths in 
meeting the needs of different groups of women. 
• Developing, disseminating and following eligibility criteria that address disparities in access 
to services by different groups of women  
 
Monitoring and evaluation 
• Develop and implement a monitoring and evaluation strategy which includes gender and 
equity indicators, such as the disaggregation of indicators of service use and factors 
affecting this by gender, age and socio-economic group 
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• Indicators should be regularly reviewed and the programme revised accordingly 
• This strategy should monitor each of the different aspects of ART provision 
 
Community involvement in developing interventions 
• Ensure the involvement of different groups of community members when developing ART 
interventions. This will require an enabling environment which allows all groups to be able to 
participate. 
• This involvement should include both the different groups of women for whom the measures 
address, as well as the people who exert an influence over those groups, such as men and 
senior family members. 
 
Addressing geographical barriers 
• Explore different options for minimising the number of journeys and travel time required to 
access ART 
• Tailor service options to the needs of different groups of women who access ART 
• Monitor the effects of innovative service provision on utilisation of services by different 
groups of women (e.g. in terms of age, socio-economic status, or marital status) 
 
Health promotion/behaviour change interventions 
• Develop and implement a health promotion strategy which addresses different groups of 
women using media accessible to these groups and non-judgemental messages 
• This strategy should be developed in collaboration with relevant groups 
• Promotional materials should aim to destigmatise HIV  
• Health information should cover all aspects of HIV and ART including symptoms, treatment, 
where and how to access treatment and addressing common myths 
 
Food and nutrition 
• Provide nutritional supplements or appropriate economic support with ART 
• To ensure that support is not diverted from women to other family members, it should be 
provided to the whole family 
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1. Introduction 
 
This report was developed in preparation of the international meeting “Ensuring universal 
access: User fee and free care policies in the context of HIV treatment”, sponsored by UNAIDS 
Secretariat, World Health Organization and the World Bank on 21-23 March 2005 in Geneva. 
The meeting will analyse the importance of the importance and impact of policy on free access 
to HIV care and treatment versus user fees, with the specific intention of identifying enabling 
mechanisms and steps to guide countries and partners in their policy decision-making process.  
 
The report considers aspects of gender dimension in access to treatment and the extent to 
which free care or co-payment at the point of service delivery intersect with gender equity in 
access to treatment within the context of scaling up.It contributes to the meeting by presenting  
a review of published literature relating to equity of access to prevention and treatment services 
for HIV/AIDS and draws on existing evidence from gender equity analyses of access to services 
for other diseases such as tuberculosis. The report provides a strategic analysis to enable the 
development of guidance for policy options. It uses case studies and key informant interviews 
from countries at various stages in their HIV epidemic and at various stages of experience with 
antiretroviral therapy (ART) provision to allow the voices of women, policy makers and 
programmers affected and infected by HIV to be heard directly.  
 
An Internet literature search was conducted using Pub Med and additional grey literature and 
published literature was sourced from individuals in the Gender and Health group.  
 
Four countries (Uganda, Kenya, Malawi, India) were selected for researching case studies and 
conducting key informant interviews. Selection was on the basis of: 
• Experience of provision of free antiretroviral drugs through public, private or NGO 
services 
• Representation of various stages in progression of the epidemic from Uganda, with an 
established epidemic to India with an emerging epidemic 
• Existing personal contacts through the Gender and Health Group and the International 
Community of Women Living with HIV 
 
A case study of free antiretroviral provision in Malawi was conducted by Research for Equity 
and Community Health Trust (REACH) using secondary health utilisation data from a service 
provision NGO and an existing qualitative study of the factors influencing access to these 
services. Key informant interviews were conducted with women living with HIV/AIDS, 
representatives of NGOs, representatives of public health services including programmers and 
policy makers. Most interviews were conducted either face to face or by telephone, but some 
informants preferred to answer questions through written correspondence.  Informants were 
identified through personal contacts, introductions by ICW and ‘snowballing’ (asking existing 
informants to identify others with experience of anti-retroviral provision).  This is not a 
representative sample of key informants, but was purposively selected to indicate a range of 
experiences and perspectives from these groups. Analysis of these interviews was carried out 
using a framework approach, whereby the broad questions asked in the interviews are used as 
a framework for grouping responses and identifying themes in the data. 
 
The report begins with an introduction of the gender dimensions of the HIV/AIDS epidemic and 
goes on to discuss the broad challenges and opportunities posed by the increasing availability 
of anti-retroviral therapies.  We then present existing evidence of gender inequities in access to 
and utilisation of diagnosis, treatment and care for HIV/AIDS and other infectious diseases, and 
discuss the factors shaping these inequities.  This evidence and the perspectives of key 
informants are then used to present the rationale for free provision of ART as a means of 
ensuring women’s access. Finally, a framework for a ‘package’ of services for the delivery of 
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free ART is suggested, with a focus on ensuring that this package is accessible to and meets 
the needs of different groups of women. 
 
1.1. Scale of epidemic and its gender dimension 
 
HIV/AIDS is having a devastating global impact with approximately 40 million people living with 
HIV worldwide in 20041. The overwhelming majority of HIV infected people live in resource poor 
settings, putting enormous strain on already hard-pressed healthcare resources. 
 
Rates of HIV infection among women are troublingly higher than those of men. Globally, young 
women (aged 15-24) are 1.6 times more likely to be living with HIV/AIDS than young men, a 
figure that rises to three times more likely in sub-Saharan Africa2. In 2003, 13 million adult (15-
49) women in sub Saharan Africa were living with the virus compared to just under 10 million 
adult men; the relative number has increased every year since 1985 when approximately half a 
million of both sexes were infected3. Even in countries, such as India, where rates of HIV 
amongst men still appear to be higher than amongst women there are significant inequities in 
access to HIV services, and vulnerable groups, such as female sex workers, face major barriers 
in accessing care. These disparities are coupled with the increased workload that is taken on by 
women as a result of the HIV epidemic – caring for children orphaned by AIDS , people sick 
with AIDS-related illnesses and their families.  
 
At the centre of this increased burden on women is the issue of gender inequity.  Factors 
influencing gender disparities in HIV rates include exploitative sexual norms, societal tolerance 
of men’s multiple partners, women’s (limited) control over their bodies and violence against 
women within relationships4. Further, limited financial resources increase women’s dependence 
upon men and hence their vulnerability to exploitation. Violence, poverty, inequality and lack of 
rights are all aspects of the battle to control HIV/AIDS5. 
 
Alongside the WHO and UNAIDS, many international organisations, including the Global Fund 
to Fight AIDS, TB and Malaria have highlighted the gender dimensions of the HIV/AIDS 
epidemic. In June 2001 , the UN General Assembly Special Session on HIV/AIDS (UNGASS) 
specifically identified the empowerment of women and increasing gender equality as central to 
decreasing females’ vulnerability to HIV/AIDS. The International Community of Women Living 
with HIV/AIDS (ICW), founded in response to the lack of support, information and services 
available to women living with HIV worldwide, have produced a number of documents 
specifically addressing the gender dimension of vulnerability to HIV/AIDS6, , 7 8
 
Local women’s organisations are already addressing the challenges faced by women who are 
infected with or affected by HIV. Positive women from many different backgrounds have worked 
together to support each other, build self esteem, challenge stigma and cultures of gender 
based violence and negotiate advances in women’s position in the household and in society. 
The subsequent growth of HIV support groups has provided a framework for women to learn 
about HIV and related health issues and in many cases to become more assertive of their 
rights9, 10. 
 
1.2. Opportunities and challenges posed by antiretroviral therapy 
 
The introduction of highly active antiretroviral therapy (ART) in industrialised countries has led 
to dramatic improvements in mortality and morbidity amongst HIV-infected individuals. Although 
ART drugs do not cure HIV, they dramatically improve quality of life and prolong survival. Six 
years after the introduction of ART in Europe and the US, deaths  from AIDS-related illness 
were cut by more than 70 per cent11. If available on a large scale in the South, ART would give 
affected communities and societies the ability to cope and live with HIV/AIDS in ways that have 
not previously been possible. However, rates of ART usage in resource poor settings are 
extremely low. Only 2% of the total number of people receiving treatment live in Africa12, and 
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less than 8% of people in the South who need ART are receiving drug treatment13. For this 
reason, many international donors have focused efforts on scaling up ART. “3 by 5” is the global 
target of the World Health Organization and UNAIDS to get three million people living with 
HIV/AIDS in the South on ART by the end of 2005. It is a step towards the goal of providing 
universal access as a human right.  
 
However, there are a number of significant challenges to meeting this goal. Firstly current ART 
scale-up programmes need to draw on lessons learnt from the scale-up of other services, such 
as voluntary counselling and testing (VCT) including priority setting for scale-up and the 
incorporation of quality assurance and monitoring and evaluation at the outset. Secondly ART 
provision poses unique programming challenges. Even in well-resourced HIV clinics the need 
for life-long therapy, increasing resistance rates, problems with adherence and high levels of 
toxicity impose significant challenges for specialist health care providers. Thirdly, ‘3 by 5’ will not 
be able to provide services to all those who need them in the immediate future, requiring difficult 
decisions about prioritisation of need. A UNAIDS and WHO sponsored consultation on ethics 
and equitable access to treatment and care for HIV/AIDS has been produced to raise 
awareness of the ethical issues and to help with the planning and implementation of the scaling-
up of ART in a way that is ethically acceptable, fair, and benefits health systems in general. The 
guidance document includes a set of measures that can be taken in countries and communities 
to promote fairness in scaling up HIV care14.  
 
There is evidence that access to existing HIV/AIDS prevention and treatment services is 
inequitable and this is likely to continue or worsen when ART is made more widely available 
unless specific measures are taken to address this in scale-up15. Small-scale programmes have 
more flexibility to address gender equity in their initial treatment programmes but their efforts 
are likely to be jeopardised by scale-up. Efforts are therefore needed to mainstream a gender 
equity focus in scale-up16.  The Global Coalition on Women and AIDS has therefore called for 
half the recipients of ART through the ‘3 by 5’ campaign to be women17. The WHO’s ‘3 by 5’ 
campaign has noted that “special attention will be given to protecting and serving vulnerable 
groups”18, but there remains a question mark over how this can be achieved in practice and who 
the most vulnerable groups are. 
 
2. Gender equity dimensions in accessing ART 
 
This section presents the existing evidence of inequities in access to prevention and treatment 
for HIV/AIDS and other communicable disease. It explores some of the underlying factors 
influencing these and highlights lessons learnt for ART programming.  In this paper the term 
‘equity’ will be used to describe differences between social groups that are judged to be 
avoidable and unfair, in contrast to ‘inequalities’ which refers simply to differences, without any 
judgement of their fairness19. 
 
2.1. Evidence of inequality of access in the HIV prevention-care continuum 
 
There is a paucity of published information disaggregated by gender, age or socio-economic 
status to indicate who is accessing ART in resource poor contexts. However, where data is 
available, it suggests that access to ART is often most common amongst educated men living in 
urban areas20, despite more women than men living with HIV/AIDS.  
 
Poor, rural women often appear to be at a particular disadvantage in accessing HIV treatment. 
In Zambia an estimated 70% of the 2 million people living with HIV/AIDS are women, and 
despite the government’s recent focus on making ART available (at the subsidised price of US 
$8 a month), only 10% of the people accessing it are women21. This inequality appears to be 
more pronounced in rural than in urban areas, where women are more often not in formal 
employment or in control of household budgets22. Where women’s social status is lower than 
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men’s and they live in a culture of obedience to husbands, fathers, brothers and other male 
relatives, women are often prevented from accessing health services23, 24.  
 
In addition, women who do not conform to social norms feel (and often are) excluded from 
mainstream HIV services25, 26, including commercial sex workers, intravenous drug users and 
HIV positive women who are pregnant or have children.  
 
Sometimes failure to access services is self-selecting in the context of women’s low bargaining 
power to protect themselves against infection. In Thika district in Kenya, only 25% of healthcare 
workers choosing to access post exposure prophylaxes (PEP) following a needle injury were 
female, despite women constituting 72% of the workforce27. Qualitative research revealed that 
they chose not to access PEP as they considered themselves constantly at risk from contracting 
HIV by having unprotected sex with their husbands.  
 
Key Informant interview: HIV positive woman, KENWA (Kenya Network of Women Living 
with HIV/AIDS) 
“Most of our women and those requiring ART are not in any form of employment, or [have an] 
income and most of them rely on their husbands or other men to provide for the basic need. So 
if they are not able to provide for the basic needs, accessing the ART is secondary, it’s not even 
considered as important. If they are not supported they cannot access the medicines.  
 
Key informant interview: Meena Seshu of Sangram, Maharastra, India  
“Sangram works with rural women because when people in rural areas are ill, chances are if 
they are men they will come and access the government health services, but if they are women 
they won’t. The problem is that most women do not access services. The men get information; 
they also go to see the doctor much faster when they are ill compared with women who are ill. 
So the people who get referred to even have an HIV test are basically the men in the family. 
The women, if they are getting tested first it is only through the antenatal clinics who are 
compulsorily testing everyone who comes in the first trimester. So women actually getting 
tested is very little. And the women who are going for testing are only going because their men 
are positive and the doctor has suggested that the sexual partner should also be tested. We 
have seen very few women whose male partners are not infected actually going in for the test.” 
 
 
2.2. Evidence of inequality of access to services in other diseases 
 
Evidence of gender inequities in access to healthcare services can be found in the context of 
other diseases. 
 
Tuberculosis: Globally there is evidence to suggest that poor women experience gender-
specific barriers to accessing TB diagnostic and treatment services, which are often greater 
than those faced by their male counterparts 28, 29, 30, 31, 32. For example in India, TB case fatality 
rates were found to be 27-41% higher amongst young women and children aged 5 -24 years 
compared with males in the same age group33. This can be partly explained by delays in 
seeking care. The low status of women, their limited decision making ability and access to 
health resources place them at particular disadvantages in comparison to men who have TB. 
Similarly a survey estimating the gender specific prevalence of TB in a district of Vietnam34, 
suggests that women ran a significant risk of under-detection. Although prevalence was similar 
for men and women, case detection was 39% amongst men and 12% in women. Under-
detection of female tuberculosis patients was explained by stigma and fear of social 
consequences, which led to women preferring to use private providers or drug sellers, who 
offered greater privacy as well as being more easily accessible. 
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Malaria: There is also evidence of lower utilisation of formal health services to treat malaria by 
women than men in some contexts.  For example, in a study of access to malaria services in 
Thailand, men attending malaria clinics outnumbered women by six to one, despite no evidence 
of significant differences in prevalence between the sexes35. Similarly, in India women between 
the ages of 25 and 39 years were severely under-represented in malaria cases recorded at 39 
Primary Health Centres, and a study in Ethiopia found that women utilised CHW services for 
malaria less frequently than expected given their proportion in the population.3637
 
Leishmaniasis: When leishmaniasis was investigated through active case finding in Columbia 
it was found to be equally prevalent among men and women. Previously it had always been 
considered twice as common in men because so many more men than women attended for 
treatment38. 
 
Onchocerciasis: In a study of treatment of onchocerciasis in Sierra Leone it was found that 
women who were excluded from having the treatment ivermectin because of pregnancy or 
breastfeeding infants, did not seek treatment once they became eligible for it. Reasons for not 
accessing treatment included the high cost of transport and not knowing where to seek 
treatment39. 
 
Leprosy: There is evidence that women delay identifying skin changes as symptoms of leprosy 
for longer than men and then depend on non-medical treatment for longer periods40. A study in 
Nigeria estimated this time delay as being twice as long in women than in men, resulting in a 
higher proportion of disabilities among women. Social stigma was a major factor for women in 
delaying accessing treatment41. This is supported by a study in central India, where women with 
leprosy were found to suffer more from rejection within their families and society42. When quality 
of care amongst people with leprosy was explored in Nepal, it was found that women received 
poorer quality of care, including attitudes of health workers, lack of information sharing and 
inadequate referrals. This affected their adherence to treatment43.  
 
2.3. Reasons for inequity of access 
 
This section explores evidence for the factors shaping inequitable access to services by women 
and men, drawing on studies of access to diagnosis, treatment and care services for HIV/AIDS 
and other communicable diseases. 
 
2.3.1. Costs 
 
2.3.1.1 Direct costs of treatment 
 
Many poor people simply do not have the funds to pay for treatment. This means that, where 
user fees are charged, they will be unable to obtain ART, will get into debt by borrowing or will 
be forced to make trade-offs in forgoing food or other essentials in order to pay for healthcare44. 
Both poor women and men have limited ability to access to ART where doing so incurs costs. 
However, the ‘feminisation of poverty’ – that poverty is “hitting increasing numbers of women, 
and is hitting them harder”45 – indicates that women are likely to have particularly low financial 
access.  
 
Research in many settings has found that women are particularly unlikely to access general 
healthcare services where payment at point of access is required46.  When user charges were 
introduced in Nigeria, maternal deaths in the Zaria region rose by 56% and the number of 
deliveries in hospitals declined by 46%47. In Zimbabwe use of maternal and child health services 
declined when user charges were enforced48 and in South Africa antenatal care improved after 
charges were withdrawn49.  
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Women often do not have equal access to those resources available within households, where 
a male head will often decide how financial resources are allocated50. When resources are 
scarce, expenditure on men and boys often takes priority over women and girls51, , 52 53. Thus if a 
household has only sufficient resources for one family member to receive ART when more are 
in need, it will usually be the male head who takes priority54, 55. This finding is supported by 
research into the intra-household allocation of resources for healthcare for other infectious 
diseases.  For example, in a study of TB in Pakistan, the unwillingness of families to pay for 
women’s treatment was found to be a major reason that women have greater difficulty 
accessing treatment than men56. Similarly in Bangladesh, it was found that households 
prioritised TB treatment for men57. 
 
Where women have some independent access to financial resources, they may be forced to 
forgo food or other essentials to pay for healthcare, or alternatively not seek healthcare in order 
to afford these basics58. Where women care for children, they will often put providing for the 
child before their own healthcare needs.  
 
The case study and key informant interviews undertaken for this paper illustrate the effects of 
paying for treatment on poor families: 
 
 
The Lighthouse, Lilongwe, Malawi 
The Lighthouse is a charitable trust in Lilongwe, Malawi, providing a continuum of care for 
people affected by and infected with HIV/AIDS, including an ART clinic.  
 
Qualitative research was undertaken at the Lighthouse to explore barriers to accessing ART at 
the time when drugs were provided ‘at cost’1. At the current exchange rate ART cost US $24 per 
month per person during this period. In a context of limited resources and costly drugs, 
individuals and families had to make very difficult decisions about who should access ART. 
There was some evidence that where men are the breadwinners they are likely to prioritise 
access to ART drugs for themselves. For example from one focus group discussion one man 
explained: ‘So the problem is that we men are selfish, selfish in the way that we are only buying 
medicines for ourselves and denying our partners the medicine as well. May be if it were halved 
but K2500… how much money do we get’. Male participant at focus group discussion 
 
Beatrice W, ICW Uganda, activist and mother 
“Women’s incomes tend to be very low, so much so that we can only afford basics really, like 
food, shelter. Those who remain in the rural areas you find that they cannot even find money, 
there is no gainful employment apart from really working the land and looking after children. You 
find that in most cases, women do not have money… The other priorities like food, clothing, 
looking after the children, eat up most of what they make - from hand to mouth. So as long as 
health care has a price tag added to it in Uganda, you will find that more and more women will 
be cut off.”  
 
 
2.3.1.2 Indirect costs of treatment 
 
Even if treatment is free, other costs can prevent women’s access to treatment. Transportation 
costs are a significant barrier to treatment for many women59, 60. Patients usually need to make 
a considerable number of journeys to visit several different health units to receive a diagnosis 
for many communicable diseases, including HIV/AIDS. Receiving a course of treatment can 
mean regular and possibly long journeys to obtain drugs. A study in Rwanda reported that many 
women living with HIV receiving medication for opportunistic diseases could not afford 
transportation to the hospital61. In Mnini in South Africa, where the government has introduced a 
                                                 
1 ART are now provided by the Lighthouse free of charge 
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free ART programme, transport is an insurmountable barrier to accessing the services for many. 
It has been next to impossible for those with AIDS-related illnesses to enrol on the free 
treatment programme, because participating in the programme requires regular visits to the 
treatment site to receive the drugs and undergo monitoring and health check-ups62. 
 
Evidence from other diseases corroborates this. Research on access to TB services in China 
found that when patients were referred to TB specialist services that offered free treatment, it 
was often difficult for them to attend these services for diagnosis and treatment due to travelling 
expenses, geographical distance and time constraints. This resulted in an average of only 20% 
of TB suspects being successfully referred to the ‘free’ services63. 
 
The cost of time spent accessing treatment services can also act as a barrier to access. This 
includes both the time spent at the health unit and the time required for travel, which is time not 
spent in productive or reproductive labour. Many poor women are not able to access services 
due to the need to earn, or produce food for their families. Even without financial constraints, 
women’s domestic responsibilities often mean they find it difficult to leave their families to travel 
to a clinic. Facilities’ hours of operation do not account for women’s domestic schedules and 
responsibilities and lack of access to transportation64. The time costs of travel is particularly 
problematic for single women (divorced, separated, widows and unmarried women) as they are 
likely to have only one source of income (their own). Time away from work means they have no 
income at all.  
 
For many types of ART medicines to be effective they need to be taken with a certain amount  
of food and water twice a day. The need to eat twice a day with medicines or plan meals 
carefully around drug regimens may require more food than usual for a poor family for whom 
financial constraints may mean they would otherwise eat only once a day. Further, the types of 
food an individual consumes may need to change in order for ART to be effective, which can be 
very difficult for a poor woman surviving at around subsistence level to afford. In situations 
where poverty limits the amount of food available and where women are the last to eat, it can be 
almost impossible for them to take ART effectively without additional support65.  
 
2.3.2. Other factors 
 
It is not only the direct and indirect costs of treatment that prevent women from accessing ART. 
A variety of other reasons interact to affect gender inequity in access to the health system and 
ART. 
 
2.3.2.1 Stigma, discrimination, blame and violence 
 
The stigma of living with HIV/AIDS is recognised to be an enormous obstacle in the fight against 
the disease. Individuals can be discriminated against and ostracised by families and 
communities, as well as institutionally, politically and legally.  
 
Where stigma exists, people often prefer to ignore their real or possible HIV status66, which 
prevents them from accessing HIV services. Although stigmatisation affects both sexes, it is 
often more extensively directed against women than against men67. For example, social stigma 
often perpetuates the belief that HIV infection is a result of "promiscuity" or "prostitution", or is 
associated with witchcraft; labels which may lead to blame or violence for women, preventing 
them from accessing treatment68, 69. Even many middle class women who can afford to 
purchase ART will not do so for fear of being seen and people learning about their status.  
 
Evidence from India has suggested that sex workers can face particular difficulty in accessing 
HIV services70. Many women fear being abandoned by their partners or families, on whom they 
are often dependent, which discourages them from discovering or disclosing their HIV status71. 
They may be accused of "promiscuity" or extra-marital sexual relations, of infecting their 
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partners or children, or of bringing shame to the families. Alternatively they may be denied 
access to ART by their families who do not want others to know of their HIV status72. 
 
Key informant interviews from Uganda illustrate the impact of stigma on access to care, even in 
a context where relative to many African countries there is a culture of openness to recognising 
HIV/AIDS. 
 
 
Male HIV worker in ART, TASO, Uganda 
“If a woman would go and disclose to their husband that they are HIV positive… that would 
imply that the blame would lie on the woman and that might disturb the social dynamics. It could 
lead to separation or divorce. So the issue of disclosure is affecting access to care” 
 
Beatrice W, ICW Uganda, activist and mother 
“Because society still looks at women as subordinate, women are easily judged when they do 
something … they are the powerless sex in the community and the family. When the woman 
walks into an AIDS clinic that is an opportunity for people to stigmatise her, blame her, name 
her and shame her. You find that most women would rather keep silent or keep away from the 
services because of fear of being named … and even being thrown out of her family, household 
or community”.  
 
 
2.3.2.2 Quality of healthcare delivery 
 
The poor quality of public healthcare services can act as a barrier to access and utilisation, 
particularly for the poor and vulnerable. One of many studies of poverty and healthcare 
identifies obstacles for the poorest presented by the low quality of health care in the public 
health system in Malawi ; the poor ‘wait longer, receive fewer drugs and pay more in 
comparison with the wealthy’73.  Poor quality and discriminatory service delivery can pose 
specific barriers to utilisation by vulnerable women74: For example, a study of access to TB 
services found women to be more sensitive than men to poor health service conditions and poor 
staff attitudes75.  The poor quality of services is often exacerbated by discrimination against 
women living with HIV/AIDS.   
 
Attitudes of healthcare staff can prevent poor and vulnerable women, particularly HIV positive 
women, from using health services. For example, pregnant women have been turned away from 
health units at delivery as a result of healthcare professionals’ fears of exposure to the virus76 
and doctors have refused to touch women with HIV77. In some situations, women who have 
been identified as HIV positive through antenatal services have been pressurised into having 
abortions or sterilisations78. Reports have emerged from Southern Africa and Asia that women 
are only allowed to access ART if they are using long term contraceptives such as the injectable 
contraceptive or the coil79. Such experiences of discrimination by health professionals against 
people living with HIV further discourage women from accessing services.  
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Key informant interview, Meena Seshu of Sangram, Maharastra, India 
“The doctors themselves tend to treat you badly. For fear of catching the infection, the doctors 
will not treat anyone who is positive. Also, the entire health infrastructure has the attitude that 
you are going to die in any case, so why should they treat you? Why should they invest money 
in this particular cause when there are so many other patients who are not HIV positive who 
should get it? There is such a tremendous negative attitude that exists from the top doctor to the 
nurses and whoever the carers are in the hospital setting. As a result people who go there come 
back with such a negative attitude that they are going to die anyway they don’t even want to 
access services later. When men encounter this, they have a voice so they fight it out, and there 
is some kind of negotiation. With women they just keep quiet and return home. That is the 
problem they are facing. How do you give women a voice, how do you teach them about their 
rights, how do you tell them that they should go and access the services because it is meant for 
them? I think is the major problem.” 
 
 
Privacy and confidentiality are key determinants of access to HIV treatment and care; the lack 
of confidentiality of services can mean that fear of stigma, discrimination and violence due to 
their HIV status prevents women from accessing care80. In some cases adolescent girls are 
refused testing or treatment unless a family member gives permission81. A case study in India 
identified a patient whose doctor told her employer about her HIV status. She was subsequently 
humiliated in front of co-workers, fired, and left without a livelihood82. This finding is supported 
by evidence from other stigmatised infectious diseases: in Bangladesh, women with TB 
identified lack of confidentiality associated with formal health services as a reason for preferring 
traditional healers83. 
 
Gendered norms and stereotypes within the health system can affect what treatment women 
and men receive and how quickly. A study in Vietnam found that women received a TB 
diagnosis on average two weeks later than men who entered the health system at the same 
time84. This may be partly due to gender bias by physicians, who are less likely to recognise the 
symptoms of what they see as a ‘male disease’ in a female patient, as found in studies of 
ischaemic heart disease in industrialised countries85.  In areas where ART is available, many 
doctors assume that women will have more difficulty adhering to complicated medication 
regimens and may be less likely to offer treatment, even though research has shown that 
women are just as likely as men to adhere to treatment86,87.  
 
‘Women friendly’ services: In order to increase women’s access, HIV services are often 
delivered via services that are used more regularly by women, such as reproductive health 
services. These services are considered to be more ‘women friendly’ because many women 
feel more at ease in these services due to their regular use, and it is socially accepted that 
women visit them. However, they are often not attractive to women who do not conform to the 
expectations of society or of staff – for example commercial sex workers, intravenous drug 
users, women considered too young to need these services, women who aren't pregnant, 
women past child-bearing age and HIV positive women who are pregnant or have children. 
These women who ‘do not conform’ can receive very poor or inappropriate services or none at 
all. Pregnant women with HIV who access health services report being forced into having 
abortions or sterilisations or turned away altogether88, 89. 
 
The inaccessibility and ‘unfriendliness’ of public sector services can result in women seeking 
care from private practitioners as the first, or only, site of service access. Although private 
practitioners charge for services, it is reported that they often adopt more caring and respectful 
attitudes towards clients in addition to being more accessible in terms of time and transportation 
costs, and offering more flexible payment options, such as spreading payment over a period of 
time and working on credit (particularly the case in small towns and villages)90. However, little is 
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known about the quality of clinical care of these private services, and supervision or regulation 
is limited, which may mean women pay to receive substandard care. 
 
2.3.2.3 Quality of clinical care 
 
Failures in the health system, including lack of adequate staff or facilities, or poor distribution 
logistics mean that even if women try to access treatment the clinical quality of services is poor; 
for example, drugs are not available or inappropriate: “everyone gets paracetamol”91. This may 
prevent women from spending the time, effort and money in accessing services.  
 
Clinical staff need to be aware of the specific clinical needs of women in relation to HIV/AIDS. 
These include clinical issues which relate to pregnant women and women’s reproductive health, 
the differences between women and men with HIV, for example, an increased risk of certain 
infections, and also differences in gynaecological problems between women with HIV compared 
with those without. Such awareness of women’s specific needs can increase their access to HIV 
services. 
 
2.3.2.4 Lack of access to information  
 
The poor frequently do not have sufficient information with which to make effective decisions 
about healthcare, such as information regarding where to find and how to access appropriate 
services 92.  A study in China found that the poor had a lower level of knowledge about the free 
treatment programme for TB, whilst women in particular were being missed by health promotion 
programmes and consequently had lower levels of knowledge and awareness of TB 
symptoms93. The health system often takes a passive attitude towards those who are unaware 
of their services or are not accessing them. The Acting National Director of the Zambian 
National AIDS Council says: “the drugs are available to both men and women – I don’t know 
why women are not accessing them.” 94  
 
Poor people frequently do not have sufficient knowledge about how to treat or manage 
symptoms, and may be misinformed about ART risks. In Botswana, Kenya and Zambia, women 
have reported returning drugs they have been given for treatment due to opposition from their 
husbands or mistaken belief (in the case of pregnant women) that they would harm the foetus95. 
Women have reported a belief that “drugs are not good for women” 96. 
 
2.3.2.5 Women’s lack of control in decision making 
 
In addition to a lack of control of financial decision-making, women may have limited control 
over their own mobility and time. A woman may not be allowed to access health services 
because society restricts her movements, or a woman’s husband may prevent her from 
obtaining treatment97. For example, in Pakistan, restrictions placed on women’s movements 
were found to be a key reason that women have greater difficulty accessing treatment than 
men98. Women’s – particularly younger women’s – ascribed domestic and childcare 
responsibilities may mean that their husbands or families do not allow them to visit health 
services.  
 
2.3.2.6 Women’s status in the household and in society 
 
Women’s position in the household and in society often means that they are not used to 
expressing their own needs. This can be particularly true for younger women. They will often 
hope that a health problem will go away on its own, meaning they will ignore signs and 
symptoms of an illness rather than go for treatment99. Some women do not want to worry their 
families with their own health problems, or to be a financial burden. In China, women with TB 
would delay care seeking so as not to use scarce resources on themselves100 and in Nepal, 
women with TB were found to wait twice as long as men before seeking treatment101.  
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There may also be additional barriers to women expressing sexual health problems.  Evidence 
from India has indicated that in some situations it is difficult for a women to talk to her husband 
about sex and sexually transmitted infections, either because it is a taboo subject or because 
she would not want to be thought to be questioning her husband and his sexual behaviour, so 
she will just ‘grin and bear it’102. 
 
Women’s legal rights such as widespread inequity in property and inheritance rights also 
influence women’s ability to access ART. Although women often have equal legal rights in law, 
in practice this is rarely observed. Where women do not inherit land or property, their wellbeing 
is considered less important than male family members as a result of this low status103. 
 
3. Rationale for free access to ART  
 
Women’s widespread lack of access to financial resources, both independently and within 
households, is a strong argument for providing free access to ART. Since women are less likely 
than men to access healthcare services which require them to pay, ART will remain 
inaccessible to poor if user fees are charged104. CHANGE therefore identifies free access as 
important to ensure equity in access to ART.  
 
Even when the costs of treatment are drastically reduced, they can remain out of reach 
financially for many poor women. In Zambia, for example, GFATM funding enabled the monthly 
cost of ART to be reduced from $64 to $8 per month. Some reports indicate that as many as 
70% of  HIV positive people in Zambia are women, so a majority of women were expected to 
access ART. Instead, men began presenting for treatment in much greater numbers. Despite 
treatment becoming much cheaper, Zambian women reported that they still lacked sufficient 
funds to pay for the monthly medication, or their families chose to pay for medication for the 
men in the household rather than the women105.  
 
The WHO identifies minimising costs to make ART more affordable as a crucial element of 
providing ART106. Women living with HIV/AIDS have specifically identified economic support 
and accessible and affordable healthcare for positive women to help improve their situation107.  
 
The provision of ART can also help reduce stigma. In India, the Society for the Protection of 
Youth and the Masses identified less stigmatising behaviour following a pilot project that trained 
health professionals to provide care as well as education around HIV108. In Haiti, the highly 
visible fact that participants receiving ART appeared healthy and were able to work reduced 
stigma dramatically109. 
 
Providing ART drugs free at the point of access will have different impacts on different groups of 
women. Poor women who are single (divorced, separated, widows and unmarried women) will 
particularly benefit, both because their income is unlikely to be sufficient to purchase ART and 
because they may not have anyone to support them if they lose their source of livelihood once 
they become ill, further reducing their ability to pay for drugs110, 111. Women without children may 
benefit from free ART where having children is an important social and cultural norm: young 
women with HIV may not be able to afford ART, and therefore run the risk of having a baby with 
HIV or decide not to have children. Free ART will give these young women opportunities to 
have healthy families112. 
 
Testimonies from people living with HIV/AIDS provide a strong case for making ART free: 
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The Lighthouse, Malawi 
“Most of the money is going to buy medicine so that to feed your family then there are also 
some children in school and it means they will to have enough money for school even in your 
family you cannot even eat decently [eat three food groups] so that because of the medicine 
other things do not go well so this in future could make some one to say it is better I just stop 
taking the medicine and die” 
 “Some of us are failing to have our partners at home get the medicine as it is expensive and I 
cannot pay K50002, and then make sure we are eating and paying rent from the same amount. I 
can’t manage, so it would help if the cost was lowered” 
 
Lillian M, ICW East African Regional Coordinator, Uganda 
“On their (women) own it is very, very difficult. Very few can afford to buy drugs on their own. 
Even if you look at the number of people who are taking drugs in this country, you realise that 
the majority of those who are paying for themselves are men, and then you have women 
infected with HIV accessing free treatment” 
 
Male HIV/AIDS worker, TASO, Uganda 
“Costing is a factor influencing access because majority of those who access barely afford 
travel costs let alone service charge” 
 
 
In summary free ART should improve access for women in the following ways: 
• Women are not dependent on their husbands or partners for purchasing treatment 
• Stigma will be reduced as more people access ART and other HIV services 
• Poor women who are divorced, separated, widowed or unmarried will particularly benefit as 
their income is unlikely to be sufficient to purchase ART and because they may not have 
anyone to support them if they lose their source of income once they become ill 
 
The next section presents existing evidence of the extent to which the free provision of ART has 
improved access to services by different groups of women. 
 
4. Evidence for the extent to which free access improves gender equity in access to 
ART 
 
There is very little published analysis of the impact on gender equity of free ART at the point of 
access. The evidence presented in this section was obtained from the case studies and key 
informant interviews undertaken for this paper in Malawi, Uganda, India and Kenya. It presents 
the experiences of free ART on people living with HIV/IADS and different service providers. 
 
                                                 
2 At the current exchange rate of 106MK:US $1, ART costs US $24 per person per month. 
12 
 
The Lighthouse, Lilongwe, Malawi 
The Lighthouse in Lilongwe, Malawi, provides a continuum of care for people affected by and 
infected with HIV/AIDS. The Lighthouse, under the umbrella of the Ministry of Health, has 
operated the ART clinic for Lilongwe Central Hospital since July 2002. Up until June 2004, 
patients paid for ART drugs at the subsidised cost of MK2500 per month. From June 2004, 
through financial support from the Global Fund for Tuberculosis, AIDS and Malaria, ART drugs 
are free of charge for all of those who are deemed clinically eligible.   
 
Using a proxy measure of poverty113 it was found that during the period when patients had to 
pay for drugs (up to June 2004), they were mostly middle class. Since June 2004, informal 
observations have revealed that the portfolio of people coming to the Lighthouse for ART has 
shifted. As well as being more women, there are more people who are less well off 
economically.  
 
In qualitative research undertaken with users of the Lighthouse, costs clearly emerged as the 
main barrier for patients to access and adhere to ART. This was the case for both female and 
male patients. The cost of accessing ART has implications for individuals, family units and the 
broader extended family networks. 
 
 
 
Bureau Chief, AIDS Healthcare Foundation, India 
“Provision of free ART has come as a boon for many women and it improves women access to 
treatment who under normal circumstance would not readily come forward either for testing or 
for care and support services for people living with HIV/AIDS.  
 
Many women from lower socio-economic groups ask to receive free ART over others things. In 
one case a very poor lady with two young daughters kept on asking for ART medications, she 
wanted ART to live longer and see her daughters grow up. She could not afford it and ultimately 
succumbed to AIDS without having the chance to use ART.” 
 
 
 
SAHAS, Gujarat, India 
SAHAS is an NGO based in Gujarat working on HIV/AIDS prevention and care since 1997. 
They currently run a private initiative providing ART subsidised by 50% to women. 
 
“Even when a cost subsidy is available, many women find it difficult to pay … Our experience is 
that free ART provision to women will definitely increase access to women as most depend on 
their family (often the income of their spouse) for payment of their own treatment. Most do not 
have any other employment. 
  
Of the 23 women attending our programme who are on ART (a programme that subsidises 
ART), seven have a spouse on ART and in four cases the husband started ART before the wife. 
The usual response from such couples is that men are the breadwinners and need to remain 
healthy, hence, when family income is not enough, priority is for the male to begin treatment  
first. If ART were free the women would be able to access treatment at the same time as the 
husbands” 
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Liverpool VCT and Care, Nairobi, Kenya and WOFAK (Women Fighting AIDS in Kenya) 
Primary research undertaken in Kenya indicated that in some situations more women than men 
are seeking HIV care than men. The director of Liverpool VCT and Care in Nairobi noted that in 
centres where there are charges more men are accessing ART as women do not have the 
finances to buy. A HIV positive woman accessing services provided by WOFAK (Women 
Fighting AIDS in Kenya) commented that before the 3 by 5 initiative the challenge to women 
accessing ART has been the cost. The introduction of free treatment allowed many women to 
access ART. 
 
An employee of Liverpool VCT and Care stated “My experience is that when people are being 
given free services they seek the services. Especially women, they are really coming when the 
services are free. Before I came to LVCT I was working at Riruta where we were giving free 
services and there are so many people who are coming. Here in Liverpool [VCT and Care in 
Nairobi] when I compare there are still people coming, but when it comes to the cost, most of 
the people are feeling it is quite high. 
 
 
 
TASO, Uganda 
TASO provides free HIV/AIDS services, including ART, and more women than men access their 
services. A male HIV/AIDS worker reported: 
  
“Close to 65% of our clients are women, and this is because women are dependent. The 
majority of them are widowed - lost their spouses and they did not have source of livelihood. 
Because TASO provides free HIV/AIDS care we have more females accessing ART and 
accessing HIV/AIDS care from TASO than males… and actually 72.7% of our patients 
accessing ART through TASO are female”  
 
This shows that free treatment is benefiting women who otherwise wouldn’t be able to afford it. 
However, it is not clear whether or where men are seeking care and this needs further 
investigation. 
 
 
 
Lillian M, ICW East African Regional Coordinator, Uganda 
 “In the first few months of the government starting to provide services providing free ART we 
have seen an increase of the number of people that come out to access the HIV services. This 
is a clear indication that probably people who are not coming out because they don’t know what 
is going to happen next, probably they knew that they could not afford. But now, with the 
provision of free ART people are coming out first of all to know their status and also to take from 
the services that are available, to come for care and support”  
 
 
Due to the paucity of published information on the impact of free ART provision, the following 
section presents evidence from studies which illustrate the impact of user fees or free treatment 
provision on women’s access to general health services or services for other infectious 
diseases.  
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5. Evidence for the extent to which free access influences gender equity in access to 
curative services for other diseases 
 
There is little documented evidence on the extent to which free access improves gender equity 
in access to curative services. However evidence indicates that the reverse is true; i.e. that fees 
for treatment make access to care more difficult for women. 
 
In Kenya, the introduction of user fees in government outpatient facilities led to a dramatic 
reduction in utilisation of sexually transmitted illnesses services by men and women. Once the 
charges were revoked, attendance by women increased to 22% above the pre-user charge 
level.114. Government hospitals of three districts in Tanzania saw a 53% decline in the utilisation 
rates of antenatal care services when user fees were introduced115. In the Zaria region of 
Nigeria, after the introduction of user fees, not only was there a decline 46% in the number of 
deliveries conducted in the main hospital, maternal deaths increased by 56%116. In South Africa, 
when charges were revoked antenatal clinic attendance increased.  
 
Free care should be seen as one of several measures which may help to increase access to 
health services117. In studies of access to TB treatment, although free or subsidised treatment 
was considered an important factor in improving access to tuberculosis care, women also cited 
stigma and fear of social isolation from family and community118, 119. A study in rural China 
revealed important perceptions of gender roles and status in rural society. Women’s status and 
economic dependency were perceived to constrain their decision making power regarding their 
own health and health care seeking behaviour120 (Xu et al 2004). 
 
In Vietnam, a study of perspectives on health seeking behaviour for TB amongst men and 
women in Vietnam revealed that amongst women, the main contributing factor to delay in 
seeking care was the fear of social isolation from family and community. Whilst in men the main 
factor was the fear of individual costs of diagnosis and treatment. This is despite the drugs for 
tuberculosis being free; there are other considerable costs including visits to the health facilities 
and one to two month hospitalisation which is the recommendation for TB treatment in 
Vietnam121. In Gambia, although cost of transport was a major issue for all participants, more 
men cited this as factor influencing their access to tuberculosis treatment. More women 
recognised stigma as the main issue122. 
 
6. Suggested ‘package’ of ‘free’ access to ART 
 
The previous two sections demonstrate the importance of providing ART free at the point of 
access to increase access by women. However, cost is only one of a number of factors that will 
result in increased use by women. Having earlier examined other factors that influence women’s 
access to HIV services, the following section uses these to develop a ‘package’ of free access 
to ART that would ensure gender equity in access to services. This includes priority-setting by 
policy-makers, engendering the WHO minimum criteria for ART provision, and other necessary 
enabling measures. 
 
6.1. Priority setting by policy makers 
 
Improving access for women should be an urgent priority for policy makers.  This needs to be 
expressed in government documents and used as a reference point by stakeholders and 
programmers.  Improving access will require considering the different and inequitable barriers 
faced by women and men across the various services supporting ART provision, including 
geographical barriers to access and unequal access to information.  Gender and age 
disaggregated monitoring and evaluation, the involvement of HIV positive women and men in 
developing and managing interventions are key strategies to mainstream gender 
considerations.   
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6.1.1. Monitoring and evaluation 
 
A key lesson that has been learnt in mainstreaming gender is the importance of gender and 
equity indicators in monitoring and evaluation strategies123. This helps ensure that gender 
awareness remains built-in to development programmes and is not forgotten as a programme or 
intervention progresses. This is particularly important in the context of scaling up, where an 
emphasis on the “3 by 5” target can mean that a focus on equity is lost. Therefore programmes 
should monitor and evaluate which social and economic groups in the population are accessing 
ART and continue to identify and address barriers that reduce the access of different groups. 
The ongoing collection of data disaggregated by gender and age can allow gender disparities to 
be identified and further explored124. The WHO has committed to collecting data disaggregated 
by gender and age for monitoring and evaluation of its ART programmes. These guidelines 
should be regularly reviewed to respond to changing circumstances or changes in the dynamic 
of the epidemic125.  
 
Qualitative research in India identified a need for such monitoring and evaluation when 
providing ART free at the point of access. An employee of Sangram, an NGO in Maharastra, 
India, working to empower HIV-positive females indicated that without a target for the proportion 
of women accessing ART and regular reviewing of gender disaggregated data, then access to 
ART would not be equitable. 
 
Recommendations: 
• Develop and implement a monitoring and evaluation strategy which includes gender 
and equity indicators, such as the disaggregation of indicators of service use and 
factors affecting this by gender, age and socio-economic group. 
• Indicators should be regularly reviewed and explored and the programme revised 
accordingly 
• This strategy should be used to monitor each of the different aspects of ART provision 
 
6.1.2. Community involvement in developing interventions 
 
Women living with HIV/AIDS have identified developments that would improve their situation. 
This has included decision-making power and consultation at all levels of policy making126. 
The WHO has identified that involving communities and family members when planning 
responses to HIV/AIDS is critical127. Such consultation allows an understanding of the health 
seeking behaviour of specific groups and the barriers they face, such as their experiences of 
denial, stigma and discrimination. Where HIV activities have explicitly involved community 
members, including them on the programme advisory boards, they have often resulted in 
successful programmes and improved participation by these groups in the programme’s 
activities128. Involving community members in all levels of decision-making is also cited as a 
successful way to challenge stigma and discrimination and promote solidarity with  people living 
with HIV/AIDS129. 
 
Involvement of community groups in decision-making and programme design also includes the 
involvement of men as a means to increasing access to HIV services by women. Including 
men in a programme can help to break down barriers between the sexes130 and can impact on 
the behaviour of both men and women. On the one hand the support of male partners can 
greatly influence a woman’s care seeking behaviour and adherence, which presents a clear 
argument for male involvement in ART promotion. On the other hand, men’s behaviour can also 
be addressed. Men may choose not to seek care for reasons of stigmatisation, which in turn 
impacts on women’s care seeking behaviour. Also men’s behaviour can place a greater burden 
on women and impact on their care seeking. For example, spending household income on 
alcohol means less disposable income for ART, and the ascription of domestic burdens solely to 
women can mean they do not have the time or resources to seek healthcare131.  
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Other groups can also influence women’s care seeking behaviour and their involvement should 
also be included, for example other members of a woman’s family and community. Qualitative 
research in Kenya found that it was considered important for community leaders to endorse 
HIV services in order to encourage others to attend132.  
 
Recommendations: 
• Ensure the involvement of different groups of community members when developing 
ART interventions at all levels: local, national and international. This will require an 
enabling environment which allows all groups to be able to participate. 
• This involvement should include both the different groups of women for  whom the 
measures are addressed, as well as the people who exert an influence over those 
groups, such as men and senior family members. 
 
6.1.3. Addressing geographical barriers 
 
We have analysed how the need to make regular visits to geographically distant health centres 
to obtain diagnosis or services can present problems for women in terms of both direct costs of 
travel and the opportunity costs of doing so. Health services can use a variety of measures to 
reach women, such as providing mobile health centres, providing child care at health centres 
and offering care to everyone in a family so that no one member is being treated at the expense 
of others133, 134. Mobile units, patient transportation for collection of drugs, 24-hour help lines and 
support to home based care can reduce the problem of transport or restricted mobility.  Key 
informants in India have indicated the need for adequately qualified staff at the village level to 
provide more geographically accessible services. Currently the lowest level provider of ART is 
often the district level, which is a significant distance to travel and limits accessibility for a large 
number of villagers135.  
 
Recommendations: 
• Explore different options for minimising the number of journeys and travel time 
required to access ART 
• Tailor service options to the needs of different groups of women who access ART 
• Monitor the effects of innovative service provision on utilisation of services by 
different groups of women (e.g. in terms of age, socio-economic status, or marital 
status) 
 
6.1.4. Health promotion/behaviour change interventions 
 
A major obstacle preventing women from accessing ART and other health services is lack of 
information. This includes lack of information about disease symptoms, treatment options, how 
or where to access treatment or that treatment may be available for free. There is a clear need 
to develop health promotion and behaviour change strategies that address groups identified as 
not accessing treatment. An employee of LVCT in Nairobi indicated that an increase in clients 
could be associated with media campaigns about ART.  
 
Women are often targeted through their care-giving or reproductive role, being identified at 
reproductive health centres or when bringing their sick children to clinics. While this  strategy is 
a common way to seek out positive women, it should not be the only method used as it 
excludes women who do not have children, or are not pregnant, including younger and older 
women too.  
 
However when addressing certain groups with information on ART, care must be taken not to 
imply that this is available only for the specific groups to the exclusion of others. For example, a 
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woman in Zambia reported that an ART campaign shaped for sex workers with sexually 
transmitted diseases left many people assuming the drugs were only available for that group136.  
 
As well as awareness, health promotion campaigns also play an important role in 
destigmatisation and acceptance of HIV and ART. Such campaigns can also address myths 
about ART that can be prevalent within a community and prevent people from accessing 
treatment. Women also need to be able to relate to role models used in promotional campaigns 
– in Kenya where promotions used well dressed city dwellers, rural women could not identify 
with them and were not encouraged to access the services they were promoting137.  
 
Recommendations: 
• Develop and implement a health promotion strategy which addresses different groups 
of women using media accessible to these groups and non-judgemental messages 
• This strategy should be developed in collaboration with the relevant groups 
• Promotional materials should aim to destigmatise HIV and attending HIV services 
• Health information should cover all aspects of HIV and ART including symptoms, 
treatment, where and how to access treatment and addressing common myths 
 
6.2. Engendering the WHO minimum requirements for ART provision  
 
The WHO has identified the following minimum requirements for making ART available:  
 
• Reliable and inexpensive HIV tests 
• Access to voluntary and confidential counselling and testing 
• Adequate management of opportunistic infections 
• Functional laboratories to monitor adverse reactions to ART 
• Training for clinicians and nurses 
• Functional social support network to improve adherence 
• Strengthening continuum of care 
• Reliable, long-term and regular supply of drugs for palliative care and opportunistic 
infections.  
• Joint decision making between doctor and patient on ART 
 
An examination of these requirements through a gendered lens provides us with an entry point 
into developing a ‘package’ of free access to ART which increases equity.  
 
6.2.1. Reliable and inexpensive HIV tests 
 
One study in Senegal, where ART is provided free, found that when the cost of drugs for 
opportunistic infections, laboratory examinations, consultations and hospitalisation fees are 
calculated, patients on ART pay an additional $130 a year138. Even if ART is provided free at the 
point of access, patients are often required to pay for tests to identify whether they are eligible 
to receive free drugs, as well as ongoing blood tests to monitor CD4 count.  
 
This paper has analysed how women are often less able to access financial resources and may 
face gendered bias and discrimination from healthcare providers. The provision of reliable, free 
HIV testing is a pre-requisite to enable women to enter the prevention and treatment continuum 
and register on free ART programmes, and free monitoring blood tests are required to keep 
them there. 
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Recommendations:  
• Reduce or eliminate costs of HIV tests, other laboratory tests, consultations, hospital 
fees and drugs for opportunistic infections to ensure that women are able to gain 
access to them 
• Monitor and evaluate the effects of free test provision on indicators of entry into the 
prevention-care continuum and adherence to treatment 
 
6.2.2. Access to voluntary and confidential counselling and testing 
 
Voluntary counselling and testing (VCT) is a vital element of the response to HIV/AIDS, often 
serving as the gateway to the continuum of prevention and care. VCT services can provide 
people who are infected with or affected by HIV with information, advice and support that they 
require to deal with their status. Counselling individuals in how to care for themselves and 
others helps prevent the further spread of HIV. Counselling can assist those wishing to learn 
their status to be psychologically prepared for the result, whether positive or negative, and to 
understand the implications for behaviour of either result. 
 
Evidence has indicated that combining testing and treatment services can help to reduce fear 
and stigma surrounding HIV as well as increasing the numbers of people accessing services 
and reinforcing prevention efforts. Where treatment is also available significant differences in 
the number of people being tested have been seen. For example, in Haiti, 4,000 people were 
tested in a nine month period at sites offering testing and treatment, compared to only 43 
people at a site that only provided testing139. It has also been found that attending counselling 
helps clients adhere to treatment regimens. For couples, the mutual support of having men and 
women in treatment together often increases the chances for both of succeeding140. 
 
However, discovering one’s HIV status through VCT services comes with risks of blame from 
family members and stigmatisation by the community and health workers141. As women are 
often particularly at risk of HIV-related stigmatisation and violence it is important that VCT 
services take careful measures to prevent this. In the Liverpool VCT Project in Kenya this has 
been specifically addressed through appropriate training of counsellors, the use of best practice 
guidelines and through service modification following client exit interviews and other quality 
assurance tools142.  
 
Recommendations:  
• Ensure VCT services, which combine testing and treatment, are available.  
• The services should develop and follow a set of best practice guidelines, which take 
into account the specific needs and priorities of different groups of women.  
• Measures to eliminate the stigma of accessing VCT services should be included, with 
a particular awareness of the interaction between gender and stigmatisation. 
 
6.2.3. Training for clinicians and nurses to improve quality of care 
 
We have discussed how poor quality clinical care and attitudes can pose barriers to women’s 
access to services. Recruiting, training and retaining healthcare staff is essential in order to 
have the resources to provide quality HIV/AIDS services.  Training for clinicians and nurses 
needs to include a consideration of the specific needs and priorities of different groups of 
women, both in terms of clinical services and social welfare.  Political will is required to sustain 
non discriminatory attitudes and practices. 
 
6.2.4. Adequate clinical knowledge 
Healthcare staff with adequate clinical knowledge are essential to ensure that appropriate 
treatment is provided to clients. Sufficient numbers and grades of staff are required for the 
number of patients a health unit serves. Confidence in the quality of care provided will 
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encourage people to spend time and effort accessing healthcare. Staff need to be trained to 
fully inform women and men of the availability of ART and its role in treatment, as well as giving 
correct and clear information regarding its usage.  This should include joint decision making 
between doctor and patient on ART so that the treatment provided meets the needs of and 
are appropriate for the patient. 
 
Equipping healthcare staff with adequate clinical knowledge should enable them to dispel 
gender-specific myths surrounding ART, for example beliefs that ‘drugs are not good for 
women’143 or that drugs will harm a pregnant women’s foetus, when in fact they have been 
passed as safe for pregnant women to use144. These beliefs can be perpetuated by health units, 
preventing women from accessing services. For example women have also reported being 
wrongly told by healthcare staff that they would die from HIV/AIDS very quickly – in a matter of 
days145. This information would very likely prevent many people from considering ART as a 
viable or worthwhile course of action. 
 
Recommendations:  
• Ensure there are sufficient numbers of appropriately trained staff available to deliver 
comprehensive ART services. Staff should be specifically trained in clinical issues 
relating to women with HIV. 
• Guidelines should be developed and followed for discussing the use of ART drugs 
with all patients, including patients who do not proactively request information.  
• Confidential treatment is essential, including confidentiality between partners or 
within families. 
• Regular monitoring and evaluation of clinical care include indicators of women’s 
specific needs and the information should be used in a quality assurance cycle to 
improve provision. 
 
6.2.5. High quality service delivery 
 
Improving the attitudes and behaviour of healthcare staff can contribute to reducing 
stigmatisation, which is key to increasing access for women. Judgemental attitudes, 
discrimination and unethical practices by health workers infringe the human rights of people 
living with HIV/AIDS and discourage use of health services. Training healthcare staff to ensure 
they understand the implications of such behaviour and the impact upon people living with HIV 
is an important step in addressing these issues.  Political will is also required to discipline staff 
engaged in discriminatory or unethical practices. 
 
A strategy used by WOFAK in Kenya is to deliberately employ people living with HIV/AIDS 
(90% of total workforce, of which the majority are women) to promote positive role models to the 
women that they work with. This also has the benefits of drawing on the knowledge and 
experiences of the positive female staff, as well as creating a supportive working environment 
for positive staff.  
 
The development of a set of standard considerations, guidelines or questions to apply to 
ART services can ensure that gender equity concerns are built into treatment access schemes. 
These guidelines can be used to ensure that patients receive appropriate treatment from 
healthcare staff. For example, when scaling up VCT services in Kenya, LVCT analysed 
qualitative and quantitative gender indicators and used the results to re-examine its VCT 
structure and delivery to ensure gender equity in VCT scale-up. Counsellors are trained to 
discuss women’s experience of sexual power relations and to provide clients with strategies for 
sexual negotiations146.  
 
Women can be discouraged by the bureaucracy surrounding the delivery of drugs, including 
understanding and signing documents if they cannot read and write, or not wanting to ask basic 
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questions for explanation or clarification of their treatment (how to take it, how often to take it, 
how long to take it for)147. Staff should be trained to fully inform patients about their treatment 
and to identify whether patients have a clear understanding of their situation, using local 
languages where necessary, both verbally and through leaflets which they can refer again to 
later.  
 
Recommendations:  
• Train healthcare staff and counsellors in non-discriminatory and gender equitable HIV 
care and treatment and raise their awareness of the different needs and priorities of 
different groups of women. 
• Involve women living with HIV/AIDS in providing HIV-related services. 
• Discipline staff involved in unethical and discriminatory practices 
• Monitor and evaluate care provision with gender indicators to ensure that gender and 
age equity concerns are built into treatment scale-up 
 
6.2.6. Functional social support network 
 
Access to a social support network not only improves adherence but has been found to be 
extremely effective in reducing the negative effects of stigmatisation experienced by women and 
in providing women with a platform to voice their views and needs. Women living with HIV/AIDS 
have called for more support through self help groups and networks when identifying 
developments that would improve their situation148. These networks can be formal or informal, 
and exist both at the local level and also at the regional, national or international levels in the 
form of support provided by committees, networks and umbrella organisations. 
 
Where women face stigma and discrimination from family and the community, as well as from 
the healthcare, political and legal systems, formal networks can provide immense support and 
solace for women with no other source of support. The experience of an HIV positive woman 
working as a programme co-ordinator for WOFAK (Women Fighting AIDS in Kenya) illustrates 
the value of support networks: 
 
“I was one person who could not come out, I was a hotelier and I found myself infected and 
when I came to WOFAK, the way I was welcomed and I was told look life goes on. I couldn’t 
believe, but with the information and the good therapy I started coming and changing my career 
to at least fit now my status. I can say that WOFAK has really helped a lot of us, me and many 
other fellow women who are out there in different fields. So again we become a bigger voice, 
you know we become visible, now at least we are noticeable. Then the other people look at our 
lives, at us sharing our own experiences; and they are able to come out … Five, ten  years back 
there was really no environment [for positive women], but now there is an environment. When 
women go to the antenatal care clinic, you find that a lot of things have changed. We find that 
the PMTCT plans has become effective because of women with HIV/AIDS they are advocating 
for such changes … Sensitising women to actually realise this is what they are supposed to do 
… When they come here for group therapies at WOFAK, they interact, we can laugh with the 
virus and cry with it. But back in the house, you go back to the cage, because they don’t know 
and you don’t want them to know because you are not ready. So we prepare them for all that” 
 
Innovative approaches to providing social support networks have been important to success 
stories in HIV service provision. COCEPWA (Coping Centre for People Living with HIV/AIDS) in 
Botswana is an NGO set up by and run by and for people living with HIV/AIDS. Although ART is 
free, stigma, fear and poverty keep many positive women from seeking help. One of 
COCEPWA’s projects is its ‘buddy’ network, in which an HIV-positive woman volunteers to 
befriend other women who are newly diagnosed, acting as a sounding board for their questions 
and fears149. These networks can be invaluable in providing support that many women would 
otherwise not receive and addressing the social barriers they face. 
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Such networks should be well integrated into the community, for example work with community 
leaders, to facilitate the spread of de-stigmatisation. A study analysing the gender dimension of 
scaling up VCT services in Kenya found that a lack of endorsement by community leaders can 
prevent women from accessing services. Qualitative research indicated that it was considered 
important for community leaders to endorse HIV services in order to encourage others to 
attend150.  
 
Informal support networks include the support received from family and friends. Such 
personal support can greatly encourage women to utilise ART and other HIV services, whilst 
lack of support prevent them from doing so, as discussed above (Section 2.3). Involving a 
woman’s family in her HIV treatment and care programme can provide her with much needed 
support in accessing and adhering to treatment. It is crucial that once enrolled in an ART 
programme, patients take the drugs consistently or risk becoming fatally ill. An informal support 
network can support, encourage and assist a women in adhering to her treatment regime – for 
example providing childcare while the woman attends clinic.  
 
HIV services providers have identified the effectiveness of working with men in their 
programmes. An antenatal clinic in Pune, India, described how working with a woman’s 
husband greatly helps retention and adherence in a context where there is a social norm of 
women’s obedience within the family151. However, it should be noted that respect for a patient’s 
privacy is first and foremost and involvement of family members should not go ahead without 
her informed consent. 
 
On the other hand if women face resistance to their treatment programmes from family 
members, a formal support network can provide information, encouragement and determination 
needed to face and overcome this opposition.  
 
In addition to local networks, women also benefit from the support of wider, regional, national 
or international networks of women living with HIV/AIDS. Such organisations are often 
established to develop solidarity between women living with HIV/AIDS, educate them about 
their rights , enabling them to create a unified voice and a forum through which to share 
experiences and develop action plans, and an advocacy platform from which to communicate 
issues of concern to policy makers. 
 
A programme co-ordinator working for WOFAK in Kenya describes the value of WOFAK as a 
national network in influencing policy: 
 
“When we sit at committees at the national level or district level, whichever level, we ensure that 
we are visible … our voices are being heard and that has really created an impact, so that it’s 
not just people living with HIV/AIDS but they are looking at it at different angle now. The policy 
makers are looking at it.” 
 
These networks and committees can also provide valuable support to positive women in 
influencing government policy to promote a culture of openness on HIV/AIDS. HIV success 
stories in resource poor settings (for example Brazil, Uganda and Thailand) have been based 
on open debates of sexual behaviour152 and influential HIV/AIDS networks can play a role in 
reducing the stigma of HIV at the wider level.  
 
There are numerous examples of women’s self help support groups and networks which have 
been set up by positive women at local, national and international levels. However there are 
much fewer examples of such networks run for or by men. This places a greater burden of care 
onto women, both within the family and within society. Men should be encouraged to find 
support from such groups so that they have a source of support and do not wholly depend upon 
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women to care for them. This will release some of the burden of care from women at the family 
level and also within the wider community. 
 
Recommendations: 
• Initiate or work with local self-help  networks of women living with HIV/AIDS. 
• Where appropriate consider involving family members in treatment schemes to 
support a woman’s treatment (however, confidentiality is foremost). 
• Link with regional, national and international networks to draw from their experience 
and connect to their wider influence. 
 
6.2.7. Strengthening the continuum of care 
 
The continuum of HIV prevention and care refers to links between the different aspects of 
HIV/AIDS prevention, treatment and care – including education, testing, VCT and ART – which 
provide service users with information on other HIV services available and provide referral 
between services. Connecting HIV services in this way can provide patients with the information 
and referral required to access other services that they need and thus increase access. 
 
Several HIV service providers and positive women amongst the key informants interviewed for 
this study identified the absence of these linkages as a key factor in low access to HIV services. 
In India and Kenya, it was noted that patients needed to proactively seek out different 
organisations for different aspects of care, including testing, care, treatment, PMTCT, 
information, social support, and economic support, which were often provided by different 
organisations.  Thus links between these services would increase access to them153, 154, 155, 156. 
 
Similarly, the ability to access a number of services in one place at the same time can improve 
access for women requiring ART, in contrast to expecting them to visit different clinics at 
different times for their own needs and the needs of their children. Organisations that provide 
family care, not necessarily exclusively for women but which take account of their specific 
needs, can encourage women to access care for themselves as well as for their families157, 158. 
 
Many women find it easier to access private providers and services provided by NGOs, due to 
their greater geographical accessibility, flexible payment options, sympathetic staff attitudes and 
more informative approaches.  This suggests that partnerships and better linkages between 
these providers and the public health system would improve women’s access to the prevention 
to care continuum. 
 
Supporting the service provided by the government health units is a strategy undertaken 
by many NGOs providing healthcare to the poor. Sangram in India identifies the utility of having 
one of their staff in public health centres,. “making public doctors treat people, cajoling them, 
forcing them, speaking sweetly, doing everything possible to just help people who need 
treatment”159.  Supporting public services in this way can be a more efficient and effective use of 
NGO resources by avoiding duplication and strengthening the services that are already 
available. 
 
There is also a strong need for multisectoral approaches in strengthening the continuum of 
HIV care. This involves working collaboratively across different government Ministries such as 
health, education, gender and community services. For example, Uganda has included 
mainstreaming HIV/AIDS prevention and control into different sectors, so that all segments of 
society have been given responsibility in taking a role160. 
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Recommendations: 
• Develop a network HIV service providers, both clinical and non-clinical, to provide 
information for patients and referral and help the different services to understand the 
specific needs of different groups of women and assist them in providing gender 
equitable services. 
 
6.2.8. Reliable, long-term and regular supply of drugs for palliative care and 
opportunistic infections. 
 
A reliable, long term and regular supply of drugs is fundamental if a course of treatment is to be 
effective and sustained. However, in many countries the number of people in need of ART 
greatly outstrips availability and access can be based on first come first served, which often 
favours male, educated, non-poor city dwellers161. The WHO identifies simplifying decision-
making regarding who accesses ART as an important early step162. The development of such 
criteria requires a specific consideration of how this can improve equity, including gender equity. 
To assist improving gender equity in access, eligibility criteria should address existing 
disparities and ensure that different groups of women are afforded equal or proportionate 
representation among selected eligible participants163. The WHO and UNAIDS recommend that 
eligibility criteria should ensure fair access to ART for vulnerable and disadvantaged groups, 
e.g. rural women, sex workers, widows and young women164. 
 
Explicit eligibility criteria made clear to staff and presented publicly is important to make ART 
access more transparent and accountable, rather than at healthcare workers’ discretion165. 
Transparent criteria could help prevent patients from being mistakenly charged for ART drugs, 
which they are in fact eligible to receive for free and discourage staff from charging fees 
fraudulently for clinic or personal income166.  
 
As well as supplying drugs for the long term, treatment programmes should also be designed to 
assist women in adhering to treatment so that their drugs are effective in the long term. 
Instead of refusing ART, where women are considered likely to default, programmes should 
assist in developing a patient’s ability to adhere to treatment. This can include the provision of 
information about HIV and treatments, skills building, practical adherence tools and aids and 
counselling about attitudes and expectations167. 
 
Recommendations: 
• Develop, disseminate and follow eligibility criteria for access to ART 
• Criteria should address disparities in access to services by different groups of 
women.  
 
In addition to these minimum requirements recommended by the WHO, our analysis of the 
factors influencing women’s access to HIV services provides us with other essential 
considerations when developing a package of free ART. 
 
6.3. Other complementary approaches needed 
 
6.3.1. Food & nutrition 
 
Lack of information about nutritional requirements to ensure the effectiveness of ART drugs or 
the costs to poor women of meeting these requirements can lead to serious side effects, 
presenting barriers to adherence and treatment continuation. Service providers and positive 
women's groups alike (eg Lynde Francis, the Centre, Harare) have identified the need for 
nutritional supplements, free food, or economic support to purchase the necessary food168, 169, 
170. However it must be considered that women’s role as carers may mean that they will 
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sacrifice this food to give to their children or family so it is important to ensure such interventions 
benefit the women who are receiving ART. 
 
Recommendations: 
• Provide nutritional supplements or appropriate economic support with ART 
• Care should be taken to ensure that these do benefit women to which they are 
provided 
 
6.3.2. Improving women’s status in society 
 
Women’s unequal access to ART and other HIV services is linked to broader empowerment and 
poverty issues. Supporting poverty reduction efforts will improve women’s access to health 
services in the long term. The improvement of women’s status can empower them to access 
information about healthcare, make independent decisions about their health and obtain the 
financial resources to afford treatment and associated costs.  UNAIDS/UNFPA/UNIFEM171 
identify the economic empowerment of women and girls as a key strategy in decreasing the 
HIV/AIDS burden on women, including increasing their access to care.  
 
7. Conclusions 
 
This paper has considered the evidence for the importance of free provision of ART to improve 
women’s equitable access to HIV/AIDS treatment and care services, as well as the 
considerable challenges to ensuring such equitable access even in this event.  Experiences to 
date of ART provision suggest that without explicit measures to improve gender equity, these 
services will be disproportionately accessed by middle-class men.  Free ART provision is a key 
priority of women living with HIV/AIDS and would represent a necessary step for gender 
equitable access.  However, free ART provision alone is unlikely to remove the many barriers to 
access by poor women, including: stigma, discrimination, blame and violence; poor quality 
public health services; gender norms and stereotypes in service provision; low access to 
information and low status and decision making power in the household and society. 
 
The planned rapid expansion of ART on a global scale provides unique opportunities for ‘getting 
it right’ and learning lessons from previous scale-up programmes and services such as VCT. If 
these lessons are not learned it is unlikely that “free by 5” will make a difference for women 
living with HIV/AIDS. This paper has drawn on these lessons to develop a framework for 
ensuring that free drugs are provided in the context of approaches to enable gender equity in 
access service provision.  The framework requires: 
 
Priority setting by policy makers with the involvement of communities of women and men living 
with HIV at all levels of decision making and from the outset. This should include: 
• An engendered monitoring and evaluation tool that is rolled out nationally  
• A commitment to reduce geographical barriers and the costs of testing and other support 
services 
• A health promotion and behaviour change strategy that explicitly considers and 
addresses the priorities and needs of different groups of women. 
• Positive work place policies supporting existing HIV positive staff  
 
Engendering the WHO minimum requirements for ART provision, including quality assured 
counselling, testing and clinical services. This should include: 
• Taking measures to reduce stigma in the provision of all services 
• Training for staff to raise awareness of gender issues and the effects of discriminatory 
and unethical practices, and disciplinary measures to prevent these practices 
• Training for staff to improve the quality of information given to clients, including 
messages to dispel common myths discouraging women from accessing treatment 
25 
• Integration of gender equity concerns into quality assurance cycles 
• Initiating or working with formal and informal support and advocacy networks of women 
living with HIV/AIDS at local, regional, national and international levels 
• Developing a formal network of HIV service providers, both clinical and non-clinical, to 
improve linkages between public, private and NGO providers, building on their strengths 
in meeting the needs of different groups of women. 
 
The provision of other enablers including ensuring adequate nutrition, and improving women’s 
status in society. 
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